Subscription of shares in Endomines AB (publ) with the

New Post Public Reply Private Reply Replies (0) Message Board

News Desk 2018

Feb 13, 2015 at 3:00 AM

Subscription of shares in Endomines AB (publ) with the exercise of warrants

The subscription of new shares in Endomines with the exercise of warrants TO 2014/2016, according to the prospectus dated November 6, 2014, will be possible from February 16 – 27, 2015. This will be followed by seven periods (May 18-29, 2015; August 18-31, 2015; November 17-30, 2015; February 16-29, 2016; May 18-31, 2016; August 18-31, 2016 and November 28 – December 9, 2016) with the same opportunity to subscribe for new shares with the exercise of warrants. The terms of the warrants · Four (4) warrants entitle the holder to subscribe for one (1) new shares in Endomines. · The subscription price is EUR 0.12 per share (for warrant registered in Finland and traded on Nasdaq Helsinki). The price in Euros is based on the fixed subscription price in Swedish kronor of SEK 1.10 per one new share. The EUR/SEK exchange rate is based on Sveriges Riksbank’s EUR/SEK exchange rate three trading days before the beginning of every subscription period. · The present subscription period is February 16 – 27, 2015. The trading in warrants on NASDAQ expires on December 7, 2016. Assuming full exercise of all warrants, Endomines will receive approximately SEK 48 million. Instructions Directly registered holders of warrants (only in Sweden) are asked to fill in an application form, which can be downloaded on Endomines’ website, www.endomines.com. Subscription takes place simultaneously with payment as instructed on the application form. Nominee registered warrant holders (in Sweden and Finland) are requested to contact their nominee for instructions regarding subscription and payment. More information on subscription with warrants is available in the prospectus for the rights issue that was published on November 6, 2014. For further information, please contact: Börje Lindén, CFO of Endomines AB, phone. +46 8 611 66 45 or visit the company´s home page: www.endomines.com. About Endomines AB Endomines conducts exploration and mining business along the 40 kilometer long Karelian Gold Line. Through various regulatory approvals, Endomines controls the exploration rights to this entire area. The Company’s first mine, Pampalo, started in February 2011. During 2014 Endomines initiated the production of ore from the mine in Rämepuro and is planning to start mining of the gold deposit in Hosko. The ore from satellite deposits will be treated in the centrally located processing plant at Pampalo. The Company’s business practices and mining operations are based on sustainable principles and on minimizing the impact on the environment. Endomines applies SveMin's & FinnMin's respective rules for reporting for public mining & exploration companies. The Company has chosen to report mineral resources and ore reserves according to the JORC-code, which is the internationally accepted Australasian code for reporting ore reserves and mineral resources. Endomines vision is to participate in the future structural transformation and consolidation of the Nordic mining industry. The Company may therefore be involved in acquisitions of interesting deposits or companies, should such opportunities arise. The shares of Endomines AB are quoted on NASDAQ Stockholm under ticker ENDO and on NASDAQ Helsinki under ticker ENDOM. The Liquidity Provider in Stockholm is Pareto Securities and Erik Penser Bankaktiebolag in Helsinki. ---------------------------------------------------------------------- Endomines AB discloses the information provided herein pursuant to the Swedish Securities Markets Act and/or the Swedish Financial Instruments Trading Act. The information was submitted for publication at 08:45 CET on February 13, 2015.

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

ROKAE Hits 10,000 Delivery Mark for Robotic Arms

ROKAE's Big 10K: A Milestone Worth Noting Alright, if you've been around the block as long as I have, you know the robotics game isn't just about making cool gadgets—it's about hitting those serious deployment numbers. ROKAE Robotics just rolled its 10,000th humanoid force-controlled arm off the line in Shandong, and this ain't just another notch on their belt. This...

Shenzhen Hosts FDI Moot: A Key Milestone for Arbitration

Shenzhen Steps into the Arbitration Spotlight In a move that's bound to tweak some eyebrows in the legal realm, Shenzhen just hosted the 2026 Foreign Direct Investment International Arbitration Moot (FDI Moot) Global Finals. This marks the first time the finals have landed on Chinese soil, and folks, that's a big deal. It’s a hefty nod to China's expanding credibility...

China's 15th Plan: Key Moves in the Capital Markets

Riding the Waves of Reform in China The winds of change are blowing through China's capital markets, and Guosen Securities is putting a stake in the ground with bold priorities for the 15th Five-Year Plan. As far as I'm concerned, the headlines here are thick with implications for anyone eyeing a piece of China's economic pie from 2026–2030. The Pillars of Stability and...

CStone's CS2009: A Leap in Cancer Treatment Validated

CStone's Game-Changer: CS2009 in the Spotlight CStone Pharmaceuticals just pulled a rabbit out of a hat at the ESMO 2026 Congress, showcasing the clinical might of their CS2009. This ain't just another hype train, folks. We're talking about a trispecific antibody targeting PD-1, VEGF, and CTLA-4. With data rolled out from over 300 patients, this compound promises a...

Elbit Systems Lands $200M APAC ISTAR Contracts

Elbit Systems Secures Major Asia-Pacific Deal You know, it's not every day that a defense contractor like Elbit Systems (NASDAQ:ESLT) bags a $200 million deal in the Asia-Pacific region. A big move in a high-stakes game where technology, strategy, and geography collide. This isn't some random supply deal; this involves the cutting edge of defense tech—ISTAR and training...

Hims & Hers Faces FTC Heat: Investor Class Action Looms

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Gildan Activewear Faces Legal Battle Over Alleged Fraud

Investor Alert: Gildan's Legal Showdown Alright, here's a twist you didn't see coming—or maybe you did if you've been tracking the ticker tapes like a hawk. Gildan Activewear Inc. (NYSE:GIL) is stuck in the kind of hot water that can scald the bottom line. The Stakes: Racing Towards December 14 Marked on your calendar, December 14, is a date of some significance if...

Zinzino Eyes European Market With New Botanical Line

Zinzino's Strategic Play in Europe's Wellness Market There's a new player on the European wellness block, and it's Zinzino's latest concoction of fermented botanical supplements. This isn't just your run-of-the-mill vitamin shop stock; we're talking about a lineup crafted for distinct parts of the day, reflecting an evolving consumer trend. People are looking for tailored...

Fluence Energy Hits Legal Snag: Investors Called to Act

Fluence Energy Faces a Securities Fraud Challenge It's like watching a slow-motion train wreck. Fluence Energy, Inc. (NASDAQ: FLNC) now finds itself in the crosshairs of a securities fraud class action lawsuit. Apparently, someone was playing fast and loose with the truth concerning their financial guidance. The period in question stretches from November 24, 2025, to...

E-Filing: Why Ditching IRS Paper Forms Matters Now

Tax Filing Today: The Old vs. The New Listen up, tax-filing warriors. Tackling that IRS Form 941 deadline isn’t just another play in the small business game—it’s crunch time. November 2, 2026, isn’t waiting around for excuses. Luckily, Halfpricesoft.com just chucked you a lifeline with their updated ezPaycheck platform. Swap that mountain of mangled paper forms...